| Dr Patricia A Daly, MD | |
|
315 W 10th St, Front Royal, VA 22630-2807 | |
| (540) 635-0800 | |
| (540) 635-0801 |
| Full Name | Dr Patricia A Daly |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 45 Years |
| Location | 315 W 10th St, Front Royal, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144387770 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 0101230384 (Virginia) | Secondary |
| 207R00000X | Internal Medicine | 0101230384 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Warren Memorial Hospital | Front royal, VA | Hospital |
| Winchester Medical Center | Winchester, VA | Hospital |
| Shenandoah Memorial Hospital | Woodstock, VA | Hospital |
| Page Memorial Hospital, Inc | Luray, VA | Hospital |
| War Memorial Hospital Inc | Berkeley springs, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Winchester Medical Center | 0244134021 | 124 |
| Warren Memorial Hospital, Inc. | 2365330347 | 71 |
| Valley Physician Enterprise Inc | 9931268091 | 205 |
News Archive
AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021.
Stressful life events are strongly associated with a person's risk for major depression, but a certain gene variation long thought to increase risk in conjunction with stressful life events actually may have no effect, according to researchers funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. The study, published in the June 17, 2009, issue of the Journal of the American Medical Association, challenges a widely accepted approach to studying risk factors for depression.
Four weeks of treatment with a combination of the drug pentoxifylline and the corticosteroid prednisolone did not improve 6-month survival compared with prednisolone alone in 270 patients with severe alcoholic hepatitis, according to a study in the September 11 issue of JAMA.
Using advanced machine-learning techniques, Georgia Tech researchers have examined nearly 1.5 million Reddit posts to identify risks associated with several of the most common alternative - and unproven - "treatments" for opioid addiction.
MiMedx Group, Inc. announced today that it has officially launched its first product, Paradis Vaso Shield(TM). In April 2009, The Food and Drug Administration cleared the Vaso Shield for use as a cover for vessels following anterior vertebral surgeries. The Vaso Shield is a permanent and transparent hydrogel product protected by multiple patents and patent applications, as well as a proprietary manufacturing process.
› Verified 1 days ago
| Entity Name | Winchester Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679711261 PECOS PAC ID: 0244134021 Enrollment ID: O20031124000061 |
News Archive
AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021.
Stressful life events are strongly associated with a person's risk for major depression, but a certain gene variation long thought to increase risk in conjunction with stressful life events actually may have no effect, according to researchers funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. The study, published in the June 17, 2009, issue of the Journal of the American Medical Association, challenges a widely accepted approach to studying risk factors for depression.
Four weeks of treatment with a combination of the drug pentoxifylline and the corticosteroid prednisolone did not improve 6-month survival compared with prednisolone alone in 270 patients with severe alcoholic hepatitis, according to a study in the September 11 issue of JAMA.
Using advanced machine-learning techniques, Georgia Tech researchers have examined nearly 1.5 million Reddit posts to identify risks associated with several of the most common alternative - and unproven - "treatments" for opioid addiction.
MiMedx Group, Inc. announced today that it has officially launched its first product, Paradis Vaso Shield(TM). In April 2009, The Food and Drug Administration cleared the Vaso Shield for use as a cover for vessels following anterior vertebral surgeries. The Vaso Shield is a permanent and transparent hydrogel product protected by multiple patents and patent applications, as well as a proprietary manufacturing process.
› Verified 1 days ago
| Entity Name | Shenandoah Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952417735 PECOS PAC ID: 2466360375 Enrollment ID: O20040115001156 |
News Archive
AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021.
Stressful life events are strongly associated with a person's risk for major depression, but a certain gene variation long thought to increase risk in conjunction with stressful life events actually may have no effect, according to researchers funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. The study, published in the June 17, 2009, issue of the Journal of the American Medical Association, challenges a widely accepted approach to studying risk factors for depression.
Four weeks of treatment with a combination of the drug pentoxifylline and the corticosteroid prednisolone did not improve 6-month survival compared with prednisolone alone in 270 patients with severe alcoholic hepatitis, according to a study in the September 11 issue of JAMA.
Using advanced machine-learning techniques, Georgia Tech researchers have examined nearly 1.5 million Reddit posts to identify risks associated with several of the most common alternative - and unproven - "treatments" for opioid addiction.
MiMedx Group, Inc. announced today that it has officially launched its first product, Paradis Vaso Shield(TM). In April 2009, The Food and Drug Administration cleared the Vaso Shield for use as a cover for vessels following anterior vertebral surgeries. The Vaso Shield is a permanent and transparent hydrogel product protected by multiple patents and patent applications, as well as a proprietary manufacturing process.
› Verified 1 days ago
| Entity Name | Page Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326040684 PECOS PAC ID: 8426951203 Enrollment ID: O20040129000420 |
News Archive
AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021.
Stressful life events are strongly associated with a person's risk for major depression, but a certain gene variation long thought to increase risk in conjunction with stressful life events actually may have no effect, according to researchers funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. The study, published in the June 17, 2009, issue of the Journal of the American Medical Association, challenges a widely accepted approach to studying risk factors for depression.
Four weeks of treatment with a combination of the drug pentoxifylline and the corticosteroid prednisolone did not improve 6-month survival compared with prednisolone alone in 270 patients with severe alcoholic hepatitis, according to a study in the September 11 issue of JAMA.
Using advanced machine-learning techniques, Georgia Tech researchers have examined nearly 1.5 million Reddit posts to identify risks associated with several of the most common alternative - and unproven - "treatments" for opioid addiction.
MiMedx Group, Inc. announced today that it has officially launched its first product, Paradis Vaso Shield(TM). In April 2009, The Food and Drug Administration cleared the Vaso Shield for use as a cover for vessels following anterior vertebral surgeries. The Vaso Shield is a permanent and transparent hydrogel product protected by multiple patents and patent applications, as well as a proprietary manufacturing process.
› Verified 1 days ago
| Entity Name | Warren Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164442281 PECOS PAC ID: 2365330347 Enrollment ID: O20040310000516 |
News Archive
AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021.
Stressful life events are strongly associated with a person's risk for major depression, but a certain gene variation long thought to increase risk in conjunction with stressful life events actually may have no effect, according to researchers funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. The study, published in the June 17, 2009, issue of the Journal of the American Medical Association, challenges a widely accepted approach to studying risk factors for depression.
Four weeks of treatment with a combination of the drug pentoxifylline and the corticosteroid prednisolone did not improve 6-month survival compared with prednisolone alone in 270 patients with severe alcoholic hepatitis, according to a study in the September 11 issue of JAMA.
Using advanced machine-learning techniques, Georgia Tech researchers have examined nearly 1.5 million Reddit posts to identify risks associated with several of the most common alternative - and unproven - "treatments" for opioid addiction.
MiMedx Group, Inc. announced today that it has officially launched its first product, Paradis Vaso Shield(TM). In April 2009, The Food and Drug Administration cleared the Vaso Shield for use as a cover for vessels following anterior vertebral surgeries. The Vaso Shield is a permanent and transparent hydrogel product protected by multiple patents and patent applications, as well as a proprietary manufacturing process.
› Verified 1 days ago
| Entity Name | Valley Physician Enterprise Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538316203 PECOS PAC ID: 9931268091 Enrollment ID: O20081104000278 |
News Archive
AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021.
Stressful life events are strongly associated with a person's risk for major depression, but a certain gene variation long thought to increase risk in conjunction with stressful life events actually may have no effect, according to researchers funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. The study, published in the June 17, 2009, issue of the Journal of the American Medical Association, challenges a widely accepted approach to studying risk factors for depression.
Four weeks of treatment with a combination of the drug pentoxifylline and the corticosteroid prednisolone did not improve 6-month survival compared with prednisolone alone in 270 patients with severe alcoholic hepatitis, according to a study in the September 11 issue of JAMA.
Using advanced machine-learning techniques, Georgia Tech researchers have examined nearly 1.5 million Reddit posts to identify risks associated with several of the most common alternative - and unproven - "treatments" for opioid addiction.
MiMedx Group, Inc. announced today that it has officially launched its first product, Paradis Vaso Shield(TM). In April 2009, The Food and Drug Administration cleared the Vaso Shield for use as a cover for vessels following anterior vertebral surgeries. The Vaso Shield is a permanent and transparent hydrogel product protected by multiple patents and patent applications, as well as a proprietary manufacturing process.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patricia A Daly, MD 315 W 10th St, Front Royal, VA 22630-2807 Ph: (540) 635-0800 | Dr Patricia A Daly, MD 315 W 10th St, Front Royal, VA 22630-2807 Ph: (540) 635-0800 |
News Archive
AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021.
Stressful life events are strongly associated with a person's risk for major depression, but a certain gene variation long thought to increase risk in conjunction with stressful life events actually may have no effect, according to researchers funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. The study, published in the June 17, 2009, issue of the Journal of the American Medical Association, challenges a widely accepted approach to studying risk factors for depression.
Four weeks of treatment with a combination of the drug pentoxifylline and the corticosteroid prednisolone did not improve 6-month survival compared with prednisolone alone in 270 patients with severe alcoholic hepatitis, according to a study in the September 11 issue of JAMA.
Using advanced machine-learning techniques, Georgia Tech researchers have examined nearly 1.5 million Reddit posts to identify risks associated with several of the most common alternative - and unproven - "treatments" for opioid addiction.
MiMedx Group, Inc. announced today that it has officially launched its first product, Paradis Vaso Shield(TM). In April 2009, The Food and Drug Administration cleared the Vaso Shield for use as a cover for vessels following anterior vertebral surgeries. The Vaso Shield is a permanent and transparent hydrogel product protected by multiple patents and patent applications, as well as a proprietary manufacturing process.
› Verified 1 days ago
Dr. Hager Salem, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 N Commerce Ave, Front Royal, VA 22630 Phone: 540-635-0800 | |
Dr. Thomas E Patteson Iii, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 W 10th St, Front Royal, VA 22630 Phone: 540-635-0800 Fax: 540-635-0801 | |
Amitkumar V Dave, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N Shenandoah Ave, Front Royal, VA 22630 Phone: 843-237-3378 Fax: 843-237-5073 | |
Furadoon A Irani, M.D Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 N Shenandoah Ave, Front Royal, VA 22630 Phone: 540-636-0280 Fax: 540-636-0281 | |
Rajdeep S Parmar, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 W Strasburg Rd, Front Royal, VA 22630 Phone: 800-969-1104 | |
Guna Subedi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 Virginia Ave, Front Royal, VA 22630 Phone: 540-635-7991 Fax: 540-636-2516 |